世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のエストロゲン治療市場 2018-2022年

Global Estrogen Therapeutics Market 2018-2022

IRTNTR23495

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年8月US$2,500
シングルユーザライセンス
110

サマリー

この調査レポートは世界のエストロゲン治療市場を分析・予測したTechNavioの市場調査報告書です。

目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
- Segmentation by product
- Comparison by product
- Estrogen gels - Market size and forecast 2017-2022
- Oral medication - Market size and forecast 2017-2022
- Suppositories - Market size and forecast 2017-2022
- Skin patches - Market size and forecast 2017-2022
- Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY ESTROGEN TYPE
- Estradiol
- Estrone
- Estetrol
- Estriol
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Key leading countries
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
- Evolution of estrogen as a therapeutic target in neurodevelopmental disorders
- Development of innovative estrogen delivery systems
- Increase in FDA approvals for new estrogen therapeutic products
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- Bayer
- Novartis
- Novo Nordisk
- Pfizer
PART 16: APPENDIX
- List of abbreviations


Exhibit 01: Parent market
Exhibit 02: Global HRT market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global - Market size and forecast 2017-2022 ($ mn)
Exhibit 10: Global - Year-over-year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition - Five forces 2017
Exhibit 19: Product - Market share 2017-2022 (%)
Exhibit 20: Comparison by product
Exhibit 21: Estrogen gels - Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Estrogen gels - Year-over-year growth 2018-2022 (%)
Exhibit 23: Oral medication - Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Oral medication - Year-over-year growth 2018-2022 (%)
Exhibit 25: Suppositories - Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Suppositories - Year-over-year growth 2018-2022 (%)
Exhibit 27: Skin patches - Market size and forecast 2017-2022 ($ mn)
Exhibit 28: Skin patches - Year-over-year growth 2018-2022 (%)
Exhibit 29: Market opportunity by product
Exhibit 30: Customer landscape
Exhibit 31: Global - Market share by geography 2017-2022 (%)
Exhibit 32: Regional comparison
Exhibit 33: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 34: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 35: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 36: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 37: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 38: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott - Vendor overview
Exhibit 47: Abbott - Business segments
Exhibit 48: Abbott - Organizational developments
Exhibit 49: Abbott - Geographic focus
Exhibit 50: Abbott - Segment focus
Exhibit 51: Abbott - Key offerings
Exhibit 52: Bayer - Vendor overview
Exhibit 53: Bayer - Business segments
Exhibit 54: Bayer - Organizational developments
Exhibit 55: Bayer - Geographic focus
Exhibit 56: Bayer - Segment focus
Exhibit 57: Bayer - Key offerings
Exhibit 58: Novartis - Vendor overview
Exhibit 59: Novartis - Business segments
Exhibit 60: Novartis - Organizational developments
Exhibit 61: Novartis - Geographic focus
Exhibit 62: Novartis - Segment focus
Exhibit 63: Novartis - Key offerings
Exhibit 64: Novo Nordisk - Vendor overview
Exhibit 65: Novo Nordisk - Business segments
Exhibit 66: Novo Nordisk - Organizational developments
Exhibit 67: Novo Nordisk - Geographic focus
Exhibit 68: Novo Nordisk - Segment focus
Exhibit 69: Novo Nordisk - Key offerings
Exhibit 70: Pfizer - Vendor overview
Exhibit 71: Pfizer - Business segments
Exhibit 72: Pfizer - Organizational developments
Exhibit 73: Pfizer - Geographic focus
Exhibit 74: Pfizer - Segment focus
Exhibit 75: Pfizer - Key offerings


?

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る